pharmaceutical investing BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
pharmaceutical investing BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026
Blue Jay Gold Announces Closing of Private Placement With Ocean Partners for Proceeds of $3.0 Million
Ucore Receives Louisiana Air Permit Covering Full 9,600 tpa Build-Out of Its Strategic Metals Complex
QIMC Sets Out Five-Phase Plan to Test Hydrogen Extraction at Bennett Hill, Nova Scotia, on the Path to Commercialization